Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Plasma Protein Therapeutics Market Size, Value And Growth Trends Through 2030
The plasma protein therapeutics market has experienced notable expansion in recent years. Valued at $34.68 billion in 2025, it is projected to reach $37.09 billion by 2026, reflecting a compound annual growth rate (CAGR) of 6.9%. This historic growth has been driven by factors such as a higher incidence of primary immunodeficiency disorders, increased reliance on immunoglobulin therapies, constraints within plasma donation infrastructure, improvements in protein purification techniques, and regulatory endorsements for plasma-derived products.
The plasma protein therapeutics market is projected to experience robust expansion over the coming years, reaching an estimated $48.98 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period is fueled by the rising demand for recombinant albumin and coagulation factors, the broader implementation of subcutaneous delivery methods, increased healthcare spending in developing economies, progress in precision medicine technologies, and a surge in public-private partnerships focused on plasma collection. Key developments shaping this period include the advancement of personalized plasma protein therapies, the growing production of recombinant proteins, the wider use of subcutaneous administration, heightened awareness regarding rare blood disorders, and improvements in supply chain and cold chain management.
Download A Free Sample Report For Comprehensive Market Insights:
Plasma Protein Therapeutics Market Industry Drivers: What Is Driving Revenue Growth?
The rising occurrence of autoimmune conditions is anticipated to drive forward the expansion of the plasma protein therapeutics market. An autoimmune disorder arises when the immune system mistakenly targets and damages the body’s own healthy cells. Therapeutic plasma exchange serves as a treatment for these conditions, which occur when the body incorrectly identifies a part of itself as foreign and generates proteins, called autoantibodies, that attack that misidentified area. A study conducted in May 2023 by the University of Glasgow, a public university in the UK, analyzed data from 22 million people and revealed that autoimmune disorders impact roughly 10% of the UK population, surpassing earlier estimates from 2022. Consequently, the growing incidence of autoimmune diseases is fueling the market’s growth for plasma protein therapeutics.
Plasma Protein Therapeutics Market Segment Analysis: What Are The Major Market Categories?
The plasma protein therapeutics market covered in this report is segmented –
1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products
2) By Route Of Administration: Intravenous, Subcutaneous
3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications
Subsegments:
1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
2) By Albumin: Human Serum Albumin, Recombinant Albumin
3) By Coagulation Factor: Factor VIII, Factor IX, Prothrombin Complex Concentrates
4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors
5) By Other Products: Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates
Plasma Protein Therapeutics Market Growth Trends: What Is Influencing The Future Outlook?
Key players in the plasma protein therapeutics industry are placing significant emphasis on developing novel offerings, including lyophilized plasma formulations, in order to address the increasing need for portable, stable, and quickly deployable blood products in emergency and pre-hospital care environments. These freeze-dried plasma products provide extended shelf life, simplified storage requirements, and faster reconstitution when compared to conventional frozen plasma, making them exceptionally appropriate for trauma care, emergency medicine, and fieldwork settings. For example, in October 2023, Octapharma AG, a Swiss pharmaceutical company, secured approval from European health regulators for the lyophilized version of its octaplasLG product. This advanced formulation facilitates convenient transfusion prior to hospital arrival, delivering rapid usability, easier handling, and enhanced stability in critical care scenarios. The product supports efficient treatment of trauma and bleeding emergencies, underscoring Octapharma’s dedication to improving patient outcomes through innovative plasma-derived therapies.
Plasma Protein Therapeutics Market Leading Companies Driving Competitive Growth
Major companies operating in the plasma protein therapeutics market are CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Shire PLC, Octapharma AG
Access The Complete Plasma Protein Therapeutics Market Report:
Plasma Protein Therapeutics Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the plasma protein therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model